Global Market Insights recently added a detailed market research study focused on the Global Influenza Diagnostic Tests Market across the global, regional and country level. The report provides 360° analysis of Influenza Diagnostic Tests Market from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Influenza Diagnostic Tests market and estimates the future trend of Global Influenza Diagnostic Tests industry on the basis of this detailed study. 

Browse key industry insights spread across 120 pages with 233 market data tables & 14 figures & charts from the report, “Influenza Diagnostic Tests Market Analysis By Test Type (Traditional Diagnostic Test {Rapid Influenza Diagnostic Test (RIDT), Direct Fluorescent Antibody Test (DFAT), Viral Culture, Serological Assay}, Molecular Diagnostic Assay {RT-PCR, Loop-mediated Isothermal Amplification-based Assay (LAMP), Nucleic Acid Sequence-based Amplification Test (NASBAT), Simple Amplification-based Assay (SAMBA)}), End-use (Hospitals, Diagnostics Centers, Research Laboratories), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/influenza-diagnostic-tests-market

In addition, the World Health Organization claims that the annual influenza epidemics during winter and autumn affect nearly 5 to 15% of the population in the Northern hemisphere. Increase in such cases would foster the need for the development of diagnostic tests for influenza.

The overall influenza diagnostic tests market has been classified on the basis of end-use, test type, and regional landscape.

Considering the test type, the market is segmented into traditional diagnostic test and molecular diagnostic assay.
Out of these two, the industry would observe substantial growth from the molecular diagnostic assay segment, which was valued at more than $668 million. Going further, industry analysts expect the segment to expand at a CAGR of 8.5% through the analysis timeline. This can be credited to the test's capability to deliver effective and accurate testing, which is in line with its ability to offer improved efficacy, resulting in enhanced outcomes.

From the end-use standpoint, the hospitals segment has been observing a stellar growth in the global influenza diagnostic tests market. The sector was valued at $565 million in 2021, with projections expecting it to grow at an unprecedented pace in the coming years. The growth would come from positive factors such as high success rate, availability of board-certified professional doctors, and faster and high effective work, amongst others.

Geographically, Latin America influenza diagnostic tests market has been gaining significant momentum over the recent years. In 2021, the regional market share was over $173 million, and is now predicted to grow at a CAGR of 8.3% over the stipulated time frame.

The regional industry development is supported by the growing pervasiveness of influenza and surging cognizance regarding the flu infection cases in the economies like Mexico, and Brazil, among others. A recent study displayed that seasonal influenza was associated with nearly 36,500 respiratory deaths and about 400,000 hospitalizations in Latin America and the Caribbean.

Abbott, Thermo Fischer Scientific Inc., Quidel Corporation, F. Hoffmann-La Roche Ltd., Meridian Bioscience Inc., DiaSorin SpA, and Dickinson and Company are some of the prominent companies operating in the global influenza diagnostic tests market.

Partial Table of Contents (ToC) of the report:
Chapter 5   Influenza Diagnostic Tests Market, By End-use
5.1    Key segment trends
5.2    Hospitals
5.2.1    Market size, by region, 2016 – 2027 (USD Million)
5.3    Diagnostics centers
5.3.1    Market size, by region, 2016 – 2027 (USD Million)
5.4    Research laboratories
5.4.1    Market size, by region, 2017 - 2028 (USD Million)
5.5    Others
5.5.1    Market size, by region, 2017 - 2028 (USD Million)
Chapter 6   Influenza Diagnostic Tests Market, By Region
6.1    Key regional trends
6.2    North America
6.2.1    Market size, by country, 2017 - 2028 (USD Million)
6.2.2    Market size, by test type, 2017 - 2028 (USD Million)
6.2.2.1   Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
6.2.2.2   Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
6.2.3    Market size, by end-use, 2016 – 2027 (USD Million)
6.2.4    U.S.
6.2.4.1   Market size, by test type, 2017 - 2028 (USD Million)
6.2.4.1.1    Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
6.2.4.1.2    Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
6.2.4.2   Market size, by end-use, 2016 – 2027 (USD Million)
Browse complete table of content of this report @ https://www.gminsights.com/toc/detail/influenza-diagnostic-tests-market
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us
Arun Hegde
Corporate Sales, USA
Global Market Insights Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com